Shopping Cart 0
Cart Subtotal
USD 0

Orpea SA (ORP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Orpea SA (Orpea) is a healthcare consulting company that offers clinical care services. The company provides services such as suite care clinic services, retirement homes, and mental hospital services, among others. Its mental hospital services include treatment of mood disorders, overuse syndromes, anxiety disorders, addiction, and psychosis forms, among others. Orpea also provides retirement homes for independent seniors, semi-invalid and dependent communities, among others. The company provides suite care services such as acute episode of a chronic disease, postoperative trauma treatment, and accident care services, among others. It has its operations in Germany, Spain, Italy and Switzerland. Orpea is headquartered in Paris, France.

Orpea SA (ORP)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Orpea SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Orpea SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Orpea SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Orpea SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8

Orpea SA, Pharmaceuticals & Healthcare, Deal Details 9

Asset Purchase 9

Orpea And Cofinimmo Acquires Ehpad, Provider Of Elderly Care Services, For USD 27.4 Million 9

Acquisition 10

Orpea to Acquire Celenus Kiniken 10

ORPEA Group to Acquire Senecura 11

Orpea Acquires Silver Care 12

Orpea Acquires Senevita 13

CPP Investment Acquires 15% Stake In Orpea For USD 441 Million 14

Orpea SA-Key Competitors 15

Orpea SA-Key Employees 16

Orpea SA-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Recent Developments 18

Financial Announcements 18

Jul 24, 2018: Orpea: Strong growth maintained in the first half of 2018, with revenue up 10.0% to EUR1,679 million 18

May 02, 2018: ORPEA Group: Strong Growth of 10.7% in Q1 2018 Revenue to EUR832m 19

Mar 27, 2018: ORPEA: Another Year of Strong Earnings Growth in 2017 20

Feb 13, 2018: ORPEA: Strong 2017 Revenue Growth of +10.5% to EUR3,138.2M, Above Guidance 23

Nov 07, 2017: ORPEA: Strong Q3 2017 Revenue Growth Of +10% To EUR797 Million 24

Sep 26, 2017: ORPEA: Strong Growth of Half-Year 2017 Results 25

Jul 18, 2017: ORPEA: Robust Increase Of +10.5% In H1 2017 Revenues To EUR1,525.9M 27

May 02, 2017: ORPEA: Strong Growth of 10.5% in Q1 2017 Revenue to EUR751.7 Million 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

Orpea SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Orpea SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Orpea SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Orpea SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Orpea SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Orpea SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7


List Of Table

List of Tables

Orpea SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Orpea SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2

Orpea SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Orpea SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Orpea SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Orpea SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8

Orpea And Cofinimmo Acquires Ehpad, Provider Of Elderly Care Services, For USD 27.4 Million 9

Orpea to Acquire Celenus Kiniken 10

ORPEA Group to Acquire Senecura 11

Orpea Acquires Silver Care 12

Orpea Acquires Senevita 13

CPP Investment Acquires 15% Stake In Orpea For USD 441 Million 14

Orpea SA, Key Competitors 15

Orpea SA, Key Employees 16

Orpea SA, Subsidiaries 17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Orpea SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.